This work sits somewhat off to the side: nearby are studies on prostate MRI, image segmentation, and weakly supervised learning, but there are almost no direct neighbors on the topic. Nevertheless, it fits into the broader current of research on the epigenetics of aging and cell identity, where methods for sequencing chromatin accessibility already exist but a scalable visual approach is missing. The optimization of ATAC-see fills this gap, making it possible to see chromatin in its native context.
The key trick: a systematic sweep of fixation and tagmentation parameters. They used 1% paraformaldehyde for 10 minutes and a 60-minute incubation with Cy5-labeled Tn5 transposase, which overcame the diffusion barrier of the crosslinked nucleus. For tissues, they added NaCl, bovine serum albumin, and an optimized permeabilization step. Signal was normalized to DNA (Hoechst), and foci of accessible chromatin were segmented automatically.
Optimized ATAC-see revealed dose-dependent chromatin opening upon treatment with trichostatin A (an HDAC inhibitor) and an age-related increase in accessibility in fibroblasts: in donors aged 22, 75, and 96 years, as well as in Hutchinson-Gilford progeria. During reprogramming with OSKM factors, a characteristic multiphasic dynamics was observed: an early burst of accessibility, a plateau, and a later decrease in H3K9me3. In mouse tissues, aging of skin and liver was accompanied by increased accessibility, whereas the heart showed a trend toward a decrease. Numerically: 60-minute tagmentation gave a signal above background, and sequencing after imaging yielded an average of 7 million unique reads.
Unlike neighboring studies that use sequencing or immunostaining of individual marks, this platform directly measures the physical accessibility of DNA in space while preserving nuclear morphology and tissue architecture. This is the first systematic optimization of ATAC-see for fixed cells and fresh-frozen tissues, opening the way to high-throughput screening of epigenetic interventions.
The method could become the basis for mapping the distribution of rejuvenated cells in organs after partial reprogramming therapy. Adaptation for clinical biopsies and automated screening of geroprotectors is possible.
It will influence gerontology, epigenetics, cell biology, and pharmacology by providing a fast and inexpensive way to assess chromatin state in response to drugs and aging.
Validation on a larger number of donors and tissues, as well as correlation with single-cell sequencing to refine cellular heterogeneity.
The connection to an unsolved problem in aging biology: how spatial reorganization of chromatin relates to loss of cell identity and whether it can be reversed. The platform offers a tool for quantifying this relationship but does not reveal the molecular mechanisms.
ATAC-see uses the same Tn5 transposase as ATAC-seq, but with a fluorescent tag: the enzyme literally "highlights" open regions of DNA, making them visible under a microscope.
The idea of visualizing the epigenetic state of cells echoes the film "Gattaca," where a genetic passport determines a person's fate. Here the chromatin landscape becomes a visible marker of age and potential reversibility.
Not published on arXiv. Here are its page, the PDF and the formalization: you can check it yourself, not only read our account.